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Abstract
The progression in the use of orthopedic implants has led to an increase in the absolute number of implant infections, triggering a search 
for more effective antibacterial coatings. Nanorattles have recently gained interest in biomedical applications such as drug delivery, as 
encapsulation of the cargo inside the hollow structure provides a physical protection from the surrounding environment. Here, silver-
containing silica nanorattles (Ag@SiO2) were evaluated for their antimicrobial potential and for their impact on cells of the immune system. 
We show that Ag@SiO2 nanorattles exhibited a clear antibacterial effect against Escherichia coli as well as Staphylococcus aureus found in 
post-operative infections. Immunotoxicological analyses showed that the particles were taken up through an active phagocytic process by 
dendritic cells of the immune system and did not affect their viability nor induce unwanted immunological effects. Silver-containing silica 
nanorattles thus fulfill several prerequisites for an antibacterial coating on surgical implants.
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Each year, a large number of patients undergo joint
replacement surgery. Postoperative prosthetic joint infection is
a severe complication after arthroplasty that affects 1% to 3% of
patients,1 leading initially to surgical and antibiotic treatment
and frequently ending with a need for replacement of the
implant.2,3 It is thus of great importance to develop intelligent
nanomaterials which prevent infections and are biocompatible at
the same time.4
With the emergence of bacterial resistance to conventional
antibiotics, silver-based compounds and silver nanoparticles
again enjoy rising popularity5–12 as antimicrobial and healing
agents.13,14 Undoubtedly, the greatest advantage of silver
originates from its multidirectional mode of action against
microbes. In contrast to single-target antibiotics, the develop-
ment of resistance is thus more difficult and requires several
sequential mutations in the bacterial cell.14,15 At concentrations
within a therapeutic window, silver does not exhibit adverse
effects toward mammalian cells while at the same time
preventing bacterial survival.14
Abbreviations: AgNPs, silver nanoparticles; Ag@SiO2, silver-
containing nanorattles; Ag@FITC-SiO2, silver-containing fluorescent nanor-
attles; TEM, transmission electron microscope; FTIR, Fourier transform
infrared spectroscopy; DLS, dynamic light scattering; FITC, fluorescein;
BMDC, bone marrow-derived dendritic cells.
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Ag(I)-containing coordination polymers demonstrate good
biocompatibility as well as antimicrobial activity, making them
promising candidates to fight biomaterial-related infections.16–18
However, despite their excellent properties, silver is released
rapidly during the first weeks after synthesis, leading to a
short-term efficacy. For a better controlled, long-term release of
silver cations, we propose to use encapsulated silver nanopar-
ticles (AgNPs) as a source of silver cations19,20 in an inorganic
nanocarrier. Nanorattles composed of silica shells may serve as
alternatives for silver-based drug delivery because of the
possibility of drug loading in their cavity.21–24 These nanorattles
present a strong advantage as they provide a physical barrier for
drug protection against the biological environment.25,26
Nanoparticles can exhibit immunological effects: particulate
material can induce the secretion of proinflammatory cytokines
by cells of the immune system27 or on the contrary suppress
immune functions.28 It is furthermore well established that
following arthroplasty, nano-sized debris detach from the
implant through wear mechanisms.29 These debris can interact
both locally and systemically with immune cells and induce the
release of proinflammatory cytokines such as interleukin-6
(IL-6). In the case of NP designed for biomedical applications
such as implant coating, it is therefore critical to carefully assess
the impact of particles on the activity of immune cells.
Despite the exceptional antimicrobial properties of AgNPs
against bacteria,30 fungi31 and viruses,32 few studies on the
preparation of antibacterial nanorattles have been reported so far.
Wei et al33 described Ag@Fe2O3 nanorattles with conjugated
glucose. This system serves as an example of multifunctional
nanorattles in which glucose captures the bacteria, silver kills
them and the magnetic shell allows the efficient removal of the
nanorattles from the contaminated drinking water.
Here, we report the synthesis of silica nanorattles filled with
silver (Ag@SiO2) made by a microemulsion approach.
34 A first
screen to assess whether the Ag@SiO2 particles fulfill a set of
requirements in order to be considered for the coating of
orthopedic implants was carried out. Antibacterial properties of
Ag@SiO2 were tested against both gram-negative and
gram-positive bacteria, while the cytotoxicity and the proin-
flammatory activity were determined with primary immune cells.
Additionally, we generated for the first time AgNPs encapsulated
inside fluorescent silica shells (Ag@FITC-SiO2) to determine
cellular uptake.
Methods
Synthesis of nanocontainers and nanorattles
Non-fluorescent and fluorescent nanorattles were prepared
under argon according to the compositions shown in Table S1.
First, 1.4 mL of water or AgNO3 (AppliChem, Darmstadt,
Germany) aqueous solution (0.01 or 0.05 or 0.1 M) was slowly
injected under vigorous stirring into a mixture consisting of
29.6 g of cyclohexane (Sigma-Aldrich, Buchs, Switzerland) and
3.5 mL of Igepal CO-520 (Sigma-Aldrich, Buchs, Switzerland)
at 28 °C. After 2 hours, 75 μL of hydrazine monohydrate (Fluka,
Buchs, Switzerland) was added and left for 2 hours. Then, silica
precursors were added dropwise: first, the non-fluorescent ones
(200 μL of tetraethyl orthosilicate (Sigma-Aldrich, Buchs,
Switzerland), 50 μL of 12.5 v/v% ethanolic solution of
APTMS) and after 1 hour, the fluorescent one (50 μL of
ethanolic solution of FITC-APTMS). After another hour, 500 μL
of 28-30% aqueous NH3 was slowly injected and the reaction
was stirred for 36 hours. The microemulsion was destabilized by
addition of 25 mL ethanol. The resulting precipitate was
collected under centrifugation (15,000 rpm, 30 min, room
temperature), washed twice with 25 mL ethanol and 25 mL
ultrapure water (15,000 rpm, 15 min, room temperature). Final
washing with 20 mL warm ultrapure water (60 °C, 40 min,
stirring) followed by centrifugation (15,000 rpm, 15 min, room
temperature) resulted in the formation of the void in the silica
spheres. Calcination of non-fluorescent NPs was performed
during TGA analysis (SDTA/TGA 851e, Mettler Toledo AG,
Greifensee, Switzerland) using aluminum crucibles (40 μL). The
measurement was conducted in the presence of nitrogen gas and
air to provide combustion of organic residues. The temperature
ranged from 25 to 600 °C, with a heating rate of 10 K min−1.
Characterization of nanocontainers and nanorattles
Morphology of the samples is characterized by transmission
electron microscopy (TEM) (CM-100 Biotwin Transmission
Electron Microscope, FEI/Philips, Hillsboro, Oregon, USA) at
the operating voltage of 80 kV, in bright field mode. Sample
preparation included a sonication of NPs in ultra-pure water. A
drop of diluted suspension was deposited on the TEM grid
(Electron Microscopy Sciences, CF 300-Cu, Carbon Film on 300
Square Mesh Copper Grids) and let to dry.
UV–Vis spectra of nanoparticle suspensions were recordedwith
UV/Vis Spectrometer (Lambda40, Perkin Elmer, Schwerzenbach,
Switzerland) at wavelengths ranging from 250 to 800 nm. The
fluorescence spectra were measured by using a Luminescence
Spectrometer LS 50B (Perkin Elmer, Schwerzenbach, Switzerland)
and the Software FL Win Lab. The samples were excited at λ =
492 nm and the spectra were measured within λ = 400-600 nm
(Ex. Slit = 5.0, Scan Speed = 100).
Silver loading and release
The amount of silver for each type of nanorattle was
determined by ICP after resuspension in nitric acid (32.5%)
with ultrasonication. For the silver loading 2-4 mg of Ag@SiO2
nanorattles were suspended in concentrated nitric acid to reach
0.3 mg mL−1 and sonicated for about 3 hours before ICP
measurements. For silver release analysis 10 mg of Ag@SiO2
nanorattles were resuspended in 5 mL water by vortexing and
sonication (30 min). After dilution to a concentration of 0.2 mg
mL−1 the suspension was split into samples of 1 mL. Those were
shaken at 37 °C (200 rpm) in the dark for the required time
periods. After centrifugation (2 h, 17,000 rpm) 0.5 mL of the
supernatant was taken for ICP analysis. Each time point was
analyzed in triplicate.
Spread plate method
Ag@SiO2-3 nanorattles were resuspended in filtrated distilled
water and sonicated for 30 minutes. In general, first 100 μL of
Ag@SiO2 suspension and then 10
3 to 106 cfu mL−1 of
2
Escherichia coli (E. coli.) K-12 TH14515 suspension was spread
on LB agar plates and incubated one day at 37 °C. As negative
control, LB agar plates without bacteria and nanorattles were
used. The assay was performed in the dark to avoid reduction of
possibly present silver cations by light.
Bacterial time-kill study
Glass tubes containing 5 mL trypticase soy broth (TSB;
Becton Dickinson and Company, Le Pont de Claix, France)
supplemented with either 0.2 mg mL−1 or 2 mg mL−1 of
nanorattles and 5 × 106 cfu mL−1 of Staphylococcus aureus
(S. aureus)113 wild-type or 1 × 106 cfu mL of E. coli 25922
were incubated at 37 °C without shaking. Bacterial survival in a
silver-free culture and in TSB served as control. Colony counts
were determined immediately before addition of silver (0 h) and
after 2, 4, 6, 8, and 24 h of incubation with silver at the
appropriate concentrations. Before sampling of the probes, the
tubes were gently vortexed and colony counts were determined
by plating aliquots of appropriate dilutions on Mueller-Hinton
agar. A bactericidal effect was defined as a ≥3-log10 (≥99.9%)
reduction of the initial bacterial count.35
Cell viability and stimulation
Bonemarrow-derived dendritic cells (BMDC)were prepared as
described in supporting information and were resuspended in
RPMI1640 (PAA, Pasching, Austria), 2 mmol mL−1 L-glutamine
(PAA, Glattbrugg, Switzerland), 1 IU mL−1 Penicillin (PAA,
Pasching, Austria), 100 mg mL−1 streptomycin (PAA, Pasching,
Austria) with 1% HEPES (PAA, Pasching, Austria), 1 mM sodium
pyruvate (PAA, Pasching, Austria), and 50 μM ß-mercaptoethanol
(Gibco Life Technologies, provided by Thermo Fisher, Carlsbad,
Califoria, United States) supplemented with 10% serum in
96-well plates at a concentration of 106 cells mL−1. Nanopar-
ticles were resuspended in pure water, vortexed, then sonicated
for 30 min. The suspension (2 mgmL−1) was added directly to the
cells to obtain final concentrations from 0.2 μg mL−1 to 500
μg mL−1, and cells were then incubated for 24 h at 37 °C under 5%
CO2. Each assay was performed in triplicate. 0.2 μg mL
−1 R848
(Invivogen, Toulouse, France) was used as a positive control for
immune activation. After centrifugation of cells (400g, 5 min),
supernatants were stored at −20 °C until ELISA analysis. For flow
cytometry, cells were resuspended in FACS buffer (PBS, 2.5%
bovine serum albumin; BSA, PAA, Pasching, Austria) and
analysis was performed using a MACSQuant Analyzer
(Miltenyi Biotec, Bergisch Gladbach, Germany). Propidium
iodide was added before measurement. Staurosporine (1 mM)
was used as positive control to induce apoptotic cell death. A
positive gate was set on CD11c + dendritic cells and data were
analyzed using FlowJo software. Interleukin-6 cytokine levels
were determined using a commercial kit according to the
manufacturer's protocol (Biolegend, London, United Kingdom)
and read using a Synergy HT reader (Bio Tek, Luzern,
Switzerland).
Nanoparticle uptake
Uptake of FITC-labeled nanoparticles into BMDC was
examined by fluorescence microscopy and flow cytometry.
BMDC were incubated with Ag@SiO2 nanorattles for 3 h in
culture medium (RPMI, 10% FCS, 2 mM L-glutamine, 1 IU mL−1
penicillin, 100 μg mL−1 streptomycin) at 37 °C in 5%CO2. 75 nM
LysoTracker (Invitrogen, provided by Thermo Fisher, Carlsbad,
Califoria, United States) and 4′,6-diamidino-2-phenyilindole
(DAPI) were used for lysosomal and nuclear staining. Cells
were visualized using a fluorescence microscope (Nikon
ECLIPSE Ni). In some conditions 10 μM cytochalasin D
(Labforce, Muttenz, Switzerland) as phagocytosis inhibitor was
added. BMDC were stained with the antibody CD11c-APC-CY7
and with propidium iodide. Cells were then washed twice and
examined by flow cytometry (MACSQuant, Miltenyi Biotec,
Bergisch Gladbach, Germany).
MTT assay
105 BMDC/well were incubated overnight in complete RPMI
at 37 °C in the presence of NP. Culture medium was replaced by
a medium without phenol red containing clear RPMI Medium
1640 (Gibco Life Technologies, provided by Thermo Fisher,
Carlsbad, Califoria, United States), 10% FCS (Gibco Life
Technologies, provided by Thermo Fisher, Carlsbad, Califoria,
United States), L-glutamine 200 mM (PAA, Pasching, Austria), and
100 IU mL−1 Penicillin 100μg mL−1 streptomycin (PAA, Pasching,
Austria), to allow photometric assessment. The tetrazolium dyeMTT
(3-(4,5-dimethylthiazol-2-ul)-2,5-diphenyltetrazolium bromide)
(Life Technologies, provided by Thermo Fisher, Carlsbad, Califoria,
United States) was added at a final concentration of 1.2 mM and cells
were incubated for 4 h at 37 °C.A freshly prepared SDS-HCl solution
(10mLHCl 0.01M, 1 g SDS)was added and cells were incubated for
Figure 1. UV–vis spectra (left) and fluorescence spectra (right) of different FITC-SiO2 and Ag@FITC-SiO2 nanorattles. The spectra were normalized.
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a further 4 h. The plate was read at 570 nm using a Synergy HT
reader.
Hemolysis assay
Sheep red blood cells (Eurobio, Courtaboeuf, France) were
coincubated with 0.2-200 μg mL−1 SiO2 or Ag@SiO2 particles
in a round bottom 96-well plate in 200 μL PBS at 37 °C, 5% CO2
for 1 h. As positive control for hemolysis, Triton X-100
(Promega, Madison, Wisconsin, United States) was used. 100 μL
supernatant was transferred to a flat bottom 96-well plate and
read by plate reader (InfinitePro M200, TECAN, Männedorf,
Switzerland) at 541 nm. Hemolysis induced by 1% Triton-X was
set as 100%.
Results
Preparation and characterization of nanocontainers and
nanorattles
SiO2 nanocontainers and Ag@SiO2 nanorattles were synthe-
sized using the water-in-oil microemulsion technique illustrated
in Figure S1. The synthesis was performed as previously
described.34 To determine their influence on cells, nanorattles
with increasing silver contents were prepared by using 0.01, 0.05
or 0.1 M of AgNO3 aqueous solution during the synthesis,
denoted as Ag@SiO2-1, Ag@SiO2-2, Ag@SiO2-3, respectively.
While SiO2 nanocontainers appear colorless, the encapsula-
tion of AgNPs yields suspensions with a color varying from
orange to dark brown (Figure S2) depending on the content of
silver, size and shape of AgNPs.36,37 At a low concentration of
AgNPs, their presence can be confirmed exclusively by UV–Vis
spectroscopy (Figure S3) due to the large background of the
silica shell. Indeed, the prepared Ag@SiO2 nanorattles exhibit a
typical surface plasmon band of crystalline spherical AgNP at
410 nm, a typical absorption band for crystalline spherical
AgNPs.38 Higher loading of AgNPs can also be detected by
X-ray diffraction (Figure S4).
For tracking the cellular uptake of the nanoparticles,
fluorescent nanocontainers (FITC-SiO2) and nanorattles
(Ag@FITC-SiO2) were prepared with fluorescein labeling
(FITC) (Table S1). Functionalization of the silica shell with a
fluorescein derivative leads to chartreuse yellow FITC-SiO2
nanocontainers and dark brown Ag@FITC-SiO2 nanorattles
(Figure S2), characterized by UV–Vis (Figure 1). At low
silver-loading, the absorption band of the AgNPs is unnoticeable
due to the relatively low content of AgNPs compared to FITC
(λmax = 494 nm). An increasing filling with silver results in a large
bandwith amaximum atλmax = 405 nmand a small shoulder in the
region of the FITC absorption. Since the presence of this small
shoulder could potentially originate from larger AgNPs,36,37,39
fluorescence spectroscopy confirmed the success of functionaliza-
tion with the fluorescent dye with an FITC emission at λmax =
513 nm (Figure 1). Moreover, FTIR spectra (Figure S5) of both
non-fluorescent and fluorescent nanoparticles demonstrated the
presence of the silica shell by exhibiting a broad band with a
shoulder at 1054 cm−1 corresponding to the Si–O–Si siloxane
bond vibrations (Figure S5).40–43
The transmission electron microscope (TEM) images of the
non-fluorescent silica nanocontainers and nanorattles with an
increasing content of silver are shown in Figures 2 and 3. In order
to study the effect of the surface properties of Ag@SiO2 on
Figure 2. TEM image of as-synthetized (A) SiO2, (B) Ag@SiO2-1, (C) Ag@SiO2-2 and (D) Ag@SiO2–3.
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biological assays, calcined Ag@SiO2 rattles were compared to
non-calcined ones. Calcination of the above-mentioned Ag@SiO2
does not significantly influence themorphology (Figure S6) even if
the NPs are more susceptible to form agglomerates. FITC-SiO2
nanocontainers demonstrate a narrow size distribution with the
outer shell diameter ranging from 25 ± 4 nm to 29 ± 6 nmwith a
wall thickness of 6.2 ± 1.1 nm (Figure S8), which is slightly
larger compared to the non-fluorescent SiO2 nanocontainers
ranging from 22 ± 4 nm to 25 ± 4 nm with a wall thickness of
5.7 ± 1.4 nm (Figure S7).
Silver loading and release
Under static conditions, the silver release from 3 to 4 μg mL−1
for all three Ag@SiO2 samples (Figure S9) is governed by the
solubility of the sample in the used medium. This release
corresponds to 50% of total silver content for Ag@SiO2-1, 10%
for Ag@SiO2-2 and 8% for Ag@SiO2-3 (Figure S10). For further
antimicrobial and toxicity investigations, the silver loading of
Ag@SiO2 was determined by ICP-OES. The silver content
increased with the amount of AgNO3 solutions used during the
synthesis from 3.3% for Ag@SiO2-1, 13.4% for Ag@SiO2-2
to 22.8% for Ag@SiO2-3.
Antimicrobial activity of Ag@SiO2 nanorattles
Postoperative prosthetic joint infections are frequently caused
by gram-positive cocci, including S. aureus, but also by
gram-negative bacilli such as E. coli. The antibacterial properties
of the Ag@SiO2 nanorattles against the model strain, E. coliK-12,
were analyzed, screening four different bacterial concentrations
(103-106 CFU mL−1) as well as four different concentrations of
Ag@SiO2-3 nanorattles (2.46, 4.67, 9.32, 19.25 mg mL
−1). The
Ag filled nanorattles demonstrated a concentration- and inoculum-
dependent effect and inhibited the bacterial growth of all inocula at
their highest concentrations (Figure 4).
The antimicrobial efficacy of the silica nanocontainers and
Ag@SiO2 nanorattles was then investigated against gram-positive
bacteria S. aureus (Figure 5, E-H), one of the most virulent strains
found in clinic for biomaterial related infections,3 and compared to
E. coli strains (Figure 5 A-D). After being incubated with bacterial
cultures at 37 °C for different time intervals, two different
concentrations (0.2 and 2 mg mL−1) of SiO2 hollow spheres
(negative controls) as well as Ag@SiO2 nanorattles with
increasing concentrations of AgNO3 (0.01 M, 0.05 M and 0.1 M)
were assessed. As shown in Figure 5, silica hollow spheres did not
inhibit the growth of both E. coli and S. aureus, while Ag@SiO2
nanorattles showed an increasing inhibitory activity when an
increasing amount of silver precursor was used. Silver has a stronger
effect against gram-negative bacteria (Figure 5 A-D) than for
gram-positive bacteria (Figure 5 E-H). After 24 h, no antibacterial
effectwas observedwithAg@SiO2-1 (Figure 5,F) andAg@SiO2-2
(Figure 5, G) for S. aureus while only 2 mg mL−1 of AgSiO2-3
(Figure 5, H) showed a decrease of around 3 log.
Uptake of SiO2 nanocontainers into immune cells
To assess the uptake of NPs into immune cells, primary
cultures of murine bone marrow-derived dendritic cells (BMDC)
were used. Dendritic cells are cells of the immune system that are
highly specialized in the uptake of particulate material and in the
initiation of immune responses against infectious pathogens.
BMDC were incubated for 3 to 4 h with fluorescently labeled
FITC-Ag@SiO2 nanoparticles and uptake was determined by
Figure 3. TEM image of (A) FITC-SiO2, (B) Ag@FITC-SiO2–1, (C) Ag@FITC-SiO2–2 and (D) Ag@FITC-SiO2-3.
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flow cytometry. As shown in Figure 6, A, cells incubated with
fluorescent nanocontainers at 37 °C demonstrate high FITC
fluorescence compared to cells incubated without nanocontai-
ners. We assessed whether the uptake of the nanoparticles was an
active process by incubating BMDC with FITC-Ag@SiO2 on
ice. Low temperatures inhibit biological processes and have been
shown to block the internalization of NPs.44 The increase in
fluorescence was largely blocked by incubation of the cells on
ice, suggesting that FITC-Ag@SiO2 uptake into BMDC is an
active biological process. The slight increase in fluorescence
seen in cells incubated with NPs on ice compared to cells without
NPs suggested that a small amount of nanocontainers adhere
passively to the cell surface.
To further characterize the uptake mechanism and verify
whether silver-containing SiO2 nanorattles were also taken up by
BMDC, we co-incubated BMDC and Ag@FITC-SiO2-3 nanor-
attles at two different concentrations for 3 h in the presence of
cytochalasin D, a phagocytosis inhibitor that inhibits the
actin-dependent uptake of NP.45 Uptake of the nanorattles is
clearly demonstrated by the concentration-dependent increase in
FITC fluorescence of BMDC (Figure 6, B). Incubation with
cytochalasin D completely blocked Ag@FITC-SiO2-3 uptake,
indicating that the particles are internalized by a phagocytic
process. The intracellular localization of the particles was then
examined by microscopy. As depicted in Figure 6, C and D,
fluorescence microscopy showed the colocalization (yellow) of
green Ag@FITC-SiO2 (Figure 6, C) and Ag@FITC-SiO2
(Figure 6, D) with the endosomal marker LysoTracker (red),
demonstrating that the NPs are concentrated in endosomal
vesicles in dendritic cells.
Impact of SiO2 particles on cellular and immunological function
To assess whether SiO2 and Ag@SiO2 particles exhibit
toxicity on BMDC, we incubated BMDC with increasing
concentrations of particles for 24 h. Viability of cells was
measured by propidium iodide incorporation. As shown in
Figure 7, A, we detected no significant decrease in cell survival
after treatment with Ag-free SiO2 particles, even at the highest
particle concentration of 200 μg mL−1. A decrease in viability
was observed in BMDC treated with Ag@SiO2 only at very
high concentrations. In terms of experimental procedure, the
Ag@SiO2 were resuspended in water and directly added to the
cell culture. Since no pre-treatment of specimens was necessary,
encapsulation of AgNPs inside silica nanocontainers seems to
provide a sufficient protection from the initial release of silver
cations, at least up to concentrations of 20 μg mL−1 AgNPs. We
also measured the hemolytic activity of SiO2 and Ag@SiO2.
Only the highest concentration of 200 μg mL−1 induced
moderate hemolysis (Figure 7, B).
Since Ag@SiO2 nanorattles only affected cell viability at
high concentrations, the next step was to verify whether these
nanorattles immunologically activate BMDC. The secretion of
the proinflammatory cytokine interleukin 6 (IL-6) was used as a
sensitive assessment of BMDC activation. As positive control,
BMDC were stimulated with resiquimod (R848), which is
Figure 4. Digital images of agar plates demonstrating antimicrobial properties of Ag@SiO2-3 nanorattles against E. coli K-12 using the spread plate method.
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known to activate immune cells and stimulate IL-6 production.46
Ag@SiO2 nanorattles did not induce IL-6 production at
concentrations ranging from 2 to 500 μg mL−1 (data not
shown). We then examined whether nanocontainers and
nanorattles impact cytokine production induced by R848. We
observed that Ag-free silica nanocontainers did not inhibit
R848-induced IL-6 secretion at concentrations up to 20 μg mL−1
(Figure 8, A). At the highest concentration of 200 μg mL−1,
nanocontainers inhibited IL-6 production by approximately
50%. The impact of as-synthesized and calcined Ag@SiO2
nanorattles containing increasing amounts of silver was also
examined. We observed that as-synthesized nanorattles inhibited
IL-6 production only at the highest NP concentration of
200 μg mL−1. In contrast, calcined Ag@SiO2 nanorattles
already inhibited IL-6 production at 20 μg mL−1 with 0.1 M
Ag (Ag@SiO2-3) and even blocked IL-6 production entirely at
200 μg mL−1 with 0.1 M Ag. In summary, we show two different
effects on IL-6 secretion: a) Ag@SiO2 nanorattles inhibit IL-6
Figure 5. Killing curves of E. coli (from A to D) and S. aureus (from E to H) at two concentrations of (A and E) SiO2, (B and F) Ag@SiO2-1, (C andG) Ag@
SiO2-2 and (D and H) Ag@SiO2-3.
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production at high Ag loadings, and b) calcined NPs containing
high loadings of Ag inhibit IL-6 production more than
non-calcined NPs.
To examine whether the immune function of BMDC was
selectively inhibited by Ag@SiO2 or whether other cellular
functions were also affected, we performed an MTT assay to
measure cellular metabolic activity due to NAD(P)H flux. We
show that metabolic activity was only moderately decreased at
NP concentrations of 2 and 20 μg mL−1 with or without Ag, but
was nearly entirely blocked at the highest NP concentration of 200
μg mL−1 in the presence of Ag (Figure 8, B). Thus, Ag@SiO2 at
the highest concentration impaired BMDC metabolism.
Discussion
In the current study we examined whether Ag-filled
nanorattles fulfill a set of essential criteria in order to be
considered for the antibacterial coating of orthopedic implants.
SiO2, Ag@SiO2, FITC-SiO2 and Ag@FITC-SiO2 nanocon-
tainers used in this study were first synthetized via the
water-in-oil microemulsion approach35 and characterized. By
varying different experimental parameters (Table S1) such as the
concentration of silver nitrate solution during the synthesis, the
extent of loading of the Ag@SiO2 could be tuned. The AgNP
presence was confirmed by UV–Vis analysis with a surface
plasmon band at 410 nm (Figure S3), a typical absorption band
for crystalline spherical AgNPs.38 Dynamic light scattering
(DLS) analysis revealed a small zeta potential of all nanorattles
(Table S2), indicating a low colloidal stability and a tendency to
agglomerate in aqueous suspensions. TEM results showed that
calcination process does not influence the morphology of the
Ag@SiO2 nanorattles (Figure S6). Filling of nanocontainers with
AgNPs results in an enlargement of the nanocontainers to a
maximum of 29 nm, while increasing the concentration of
AgNO3 from 0.01 M, 0.05 M to 0.1 M allows tuning of the AgNPs
size (10.5 ± 2.2 nm, 14.3 ± 2.6 nm and 16.4 ± 3.8 nm,
respectively).
The antimicrobial activity of the Ag@SiO2 nanorattles was
investigated against two types of bacteria that are frequently
involved in infectious complications of orthopedic implants, the
gram-positive S. aureus and the gram-negative E. coli. Indeed,
S. aureus causes more than 50% of all implant-associated
infections.3,47–49 Gram-negative bacteria are more sensitive
against Ag@SiO2 than gram-positive bacteria, also demonstrated
by Klapiszewski and co-workers50 The comparison of the
antimicrobial efficacy of silica nanorattles with different silver
loadings (Figure 5) shows a clear supremacy of the nanorattles
with higher silver loading. Indeed the bacterial growth was
inhibited when the concentration of Ag@SiO2 increased to
2 mg mL−1. Ag@SiO2 Nanorattles demonstrated a typical
dose-dependent effect against E.coli strains. This is in agreement
with previous studies of Das et al,51 and Parandhaman et al,52 in
which nano-silica silver composites exhibited antibacterial
activities with 99.9% killing effect. The dose-dependency can
be explained by the continuous uptake of silver by the bacteria,
Figure 6. Uptake of FITC-SiO2 nanocontainers by BMDC. (A and B) BMDC were incubated for 3 h with FITC-labeled Ag@SiO2 and uptake by CD11c
+
BMDC was assessed by flow cytometry. (C and D) Fluorescent micrographs of BMDC incubated for 3 h with 50 μg mL−1 FITC-labeled Ag@SiO2 (C) or
FITC-labeled Ag@SiO2 containing 0.1 M AgNO3 (D). Green: FITC-labeled nanoparticles, red: lysoTracker (endosomal marker), blue: cell nuclei (DAPI).
Yellow: merged green and red.
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which leads to a non-static, hence continuous release of silver
from the nanorattle reservoirs until bacteria are killed. This is
realized with the highest loaded nanocontainers.
We have studied the interaction of Ag@SiO2 with mouse
dendritic cells, which play an essential role in the initiation and
control of immune responses. These cells are able to phagocytose
particulate bodies and, upon activation, to produce high amounts
of cytokines, which are essential messengers of immunity.53–55
Indeed, dendritic cells are key regulators of both immune
tolerance and antimicrobial immunity. The study of the impact of
NP on the function of dendritic cells is therefore of utmost
importance for future clinical applications.
According to their size and morphology, nanoparticles can be
internalized into cells by either passive or active pathways.56 Since
the majority of the SiO2 nanocontainers does not exceed 30 nm in
diameter, their uptake can be expected to follow the endocytic
pathway.57 However, as it was demonstrated by TEM images and
confirmed by DLS measurements, the silica shells tend to form
agglomerates which could modify the cellular uptake. We
demonstrate here that Ag@SiO2 nanorattles are actively taken up
by dendritic cells in an actin-dependent process and can subsequently
be found in the endosome, suggesting an uptake by phagocytosis.
It is known that the NP surface becomes coated with
biomolecules present in biological fluids in a phenomenon called
the corona. The composition of the corona is dependent on the
environment and can influence NP uptake in certain cell types.58
In our study, the cellular uptake experiments were performed in
standard cell culture medium containing 10% fetal calf serum,
which differs from physiological conditions found in the
organism. Thus, although dendritic cells are well known to
take up many different types of NP,58 it will be important to
verify uptake of Ag@SiO2 NPs by dendritic cells in future
in vivo studies.
The cytotoxicity of nanomaterials is clearly size-dependent.59
Choi et al showed, for example, that silicon nanoparticles are
more cytotoxic than larger silicon microspheres due to
Figure 7. Effect of SiO2 nanocontainers and Ag@SiO2 nanorattles on BMDC and red blood cell viability.BMDC were treated with increasing concentrations of
SiO2 hollow spheres or Ag@SiO2 nanorattles containing increasing concentrations of AgNO3. (A) Viability was measured by propidium iodide incorporation
into CD11c+ cells. (B) Sheep red blood cells were incubated for 1 h with increasing concentrations of nanoparticles. Absorbance of supernatant was measured at
541 nm.
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differences in the specific surface area, the number of particles at
the equivalent gram concentration and the internalization
pathway.60 The cytotoxicity of silver is highly dependent on
its concentration: within a defined therapeutic window it has
antimicrobial properties but does not affect mammalian cells,
making it an effective antibacterial agent.14 We show here
that neither SiO2 nanocontainers nor Ag@SiO2 nanorattles affect
the viability of dendritic cells except at the highest concentra-
tions. The highest concentrations of Ag@SiO2 nanorattles
(200 μg mL−1) also impair dendritic cell metabolism measured
by MTT assay.
Some nanoparticles such as nano-TiO2 have been shown to
activate BMDC and other immune cell subsets to produce
proinflammatory cytokines.27 This activation occurs through the
NLRP3 inflammasome, a cytosolic protein complex. Such a
proinflammatory activity would be highly undesirable in
materials used for coating surgical implants, as this might result
in chronic inflammation at the site of the implant, which could
compromise its integrity and function. We have observed here
that Ag@SiO2 nanorattles do not induce the proinflammatory
cytokine IL-6, even at high concentrations of NP. Thus, we show
that dendritic cells readily phagocyte Ag@SiO2 NP but that in
contrast to the uptake of TiO2 NP, they are not activated
following internalization.
While the materials coating implants should not spontane-
ously induce inflammation, these materials should not inhibit the
activity of local immune cells. We have mimicked the initiation
of an immune response by using R848, an activator of the
Toll-like receptor 7. This molecule initiates a strong immune
response in dendritic cells by inducing the production of
cytokines. We have demonstrated that as-synthesized Ag@SiO2
nanorattles do not impair immune activation of BMDC upon
R848 stimulation for concentrations up to 20 μg mL−1 NP and
0.1 MAgNO3. Under the same conditions, calcinated nanorattles
do decrease the production of IL-6 in an Ag concentration-
dependent manner.
In conclusion, we have demonstrated that silica-encapsulated
Ag has strong antibacterial properties at a concentration that is
neither hemolytic nor affects the viability of phagocytic cells.
Furthermore, Ag@SiO2 NPs did not induce inflammation and
did not impair immune responses at this concentration. As it is
clear that nanoparticulate debris are released by wear in the case
of orthopedic implants, and that these debris are taken up by
dendritic cells and other immune cells, it was essential to clarify
the absence of toxicity and of adverse effects on the immune
system for Ag@SiO2 NPs in particulate form. In further studies,
it will be necessary to confirm the antibacterial effect of Ag@SiO2
NPs when immobilized as coating on implant material. Thus,
we have shown that Ag@SiO2 NPs fulfill important
prerequisites for their application as antibacterial coating of
surgical implants.
Appendix A. Supplementary data
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.nano.2016.08.002.
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